24/7 Customer Support

Asia Pacific Continuous Glucose Monitoring Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2030

Asia Pacific Continuous Glucose Monitoring Market- (By Component – Sensors, Transmitters & Receivers, Integrated Insulin Pumps, and Others; By Demographics - Child Population (<14 years) and Adult Population (>14 years); By End Users - Diagnostics/Clinics, ICUs, and Home Healthcare; and By Country) - Industry Dynamics, Market Size and Opportunity Forecast, 2030

  • Published On: 04-May-2022  |   Format: pdfpowerpointexcel  |  Report ID: AA0522220
    Delivery: 2 to 4 Hours
Asia Pacific Continuous Glucose Monitoring Market

View Full Infographic


Continuous glucose monitoring automatically tracks blood glucose levels, also called blood sugar, throughout the day and night on a continual basis by insulin-requiring people with diabetes. 

A continuous glucose monitor consists of three parts: a small electrode placed under the skin, a transmitter sending readings at regular intervals (ranging from every 5 to 15 min), and a separate receiver.

China has the highest prevalence of diabetes in Asia Pacific. 

The Asia Pacific Continuous Glucose Monitoring Market was valued at US$ 1,081.6 Mn in 2021. 

The Asia Pacific CGM market is projected to expand at a CAGR of 12.22% over the forecast period. 

The market is majorly driven by factors such as increased awareness among people towards monitoring and preventive health and surge in diabetic population.

CGM devices can be expensive, and the results might not be as accurate as a fingerstick check.

Sensors dominate the market in 2021.

Home healthcare segment are the highest end-users in the Asia Pacific Continuous Glucose Monitoring Market in 2021. 

China dominates the Asia Pacific CGM market.

India records the highest CAGR in the Asia Pacific CGM market. 

The key players in the Asia Pacific CGM market are Medtronic Plc, Abbott Lab, DexCom Inc., Senseonics Holding Inc., and Johnson & Johnson among others.